Rubin Jonathan
Transaction: 07/29/2026
BUY
Change
+750
Price
Not reported
Filing
07/31/2026
Type
BUY
Supernus Pharmaceuticals, Inc.
SUPN • Drug Manufacturers - Specialty & Generic
$43.53
▼ -0.44 (-1.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$2.51B
Growth
23.0%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 0.81Consistent free cash flow · 5/5Manageable debt level · 0.04Healthy liquidity · 1.9Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$43.53
Change-1.00%
Market Cap$2.51B
52W Range38.26 - 59.68
Beta0.56
Gross Margin89.63%
Oper. Margin-5.13%
Profit Margin-5.36%
Debt/Eq0.04
Current Ratio1.90
Quick Ratio1.66
Revenue 5Y23.03%
Price$43.53
Change-1.00%
Market Cap$2.51B
52W Range38.26 - 59.68
Beta0.56
Gross Margin89.63%
Oper. Margin-5.13%
Profit Margin-5.36%
Debt/Eq0.04
Current Ratio1.90
Quick Ratio1.66
Revenue 5Y23.03%
Target$65.00
Target Upside49.32%
Target Median$65.00
Target Range65.00 - 65.00
Volume3.04M
Avg Volume815.46K
EPS Surprise0.31
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
40/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score▼
Positive free cash flow · 0.81Consistent free cash flow · 5/5Manageable debt level · 0.04Healthy liquidity · 1.9Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$65.00
Mean
$65.00
Median
$65.00
High
$65.00
Insider Transactions
Recent executive and insider activity
Bhatt Padmanabh P.
Transaction: 07/29/2026
BUY
Change
+2,500
Price
Not reported
Filing
07/31/2026
Type
BUY
Mottola Frank
Transaction: 07/29/2026
BUY
Change
+1,650
Price
Not reported
Filing
07/31/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rubin Jonathan | BUY | +750 | Not reported | 07/29/2026 | 07/31/2026 |
| Bhatt Padmanabh P. | BUY | +2,500 | Not reported | 07/29/2026 | 07/31/2026 |
| Mottola Frank | BUY | +1,650 | Not reported | 07/29/2026 | 07/31/2026 |
| DEC TIMOTHY C | BUY | +1,250 | Not reported | 07/29/2026 | 07/31/2026 |
| Khattar Jack A. | BUY | +29,849 | Not reported | 07/29/2026 | 07/31/2026 |
| Bhatt Padmanabh P. | SELL | -7,250 | $39.40 | 03/18/2026 | 03/18/2026 |
| Bhatt Padmanabh P. | SELL | -412 | $50.48 | 03/18/2026 | 03/18/2026 |
| Bhatt Padmanabh P. | SELL | -12,250 | $36.75 | 03/17/2026 | 03/18/2026 |
| Bhatt Padmanabh P. | SELL | -22,290 | $50.73 | 03/17/2026 | 03/18/2026 |
| Bhatt Padmanabh P. | SELL | -4,250 | $29.61 | 03/16/2026 | 03/18/2026 |
| Bhatt Padmanabh P. | SELL | -15,886 | $50.49 | 03/16/2026 | 03/18/2026 |
| Khattar Jack A. | SELL | -120 | $51.75 | 03/13/2026 | 03/16/2026 |
| Hudson Frederick M. | SELL | -5,369 | $50.61 | 03/12/2026 | 03/16/2026 |
| Horich William Todd | SELL | -4,439 | $55.00 | 03/10/2026 | 03/10/2026 |
| Horich William Todd | SELL | -4,438 | $54.00 | 03/09/2026 | 03/10/2026 |
| Mottola Frank | SELL | -1,623 | $53.65 | 03/09/2026 | 03/10/2026 |
| Horich William Todd | SELL | -1,125 | Not reported | 03/06/2026 | 03/10/2026 |
| Horich William Todd | SELL | -1,216 | $54.73 | 03/06/2026 | 03/10/2026 |
| DEC TIMOTHY C | SELL | -3,000 | Not reported | 03/06/2026 | 03/10/2026 |
| DEC TIMOTHY C | SELL | -1,433 | $54.73 | 03/06/2026 | 03/10/2026 |